Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


29.10.2018

1 Am J Gastroenterol
1 Cancer Lett
1 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
1 Eur J Cancer
5 Eur J Surg Oncol
1 Int J Cancer
2 Int J Oncol
1 J Gastroenterol Hepatol
1 Lancet
2 Lancet Oncol
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. RUGGE M, Genta RM, Fassan M, Valentini E, et al
    OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0353.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. ESPINOZA JL, Matsumoto A, Tanaka H, Matsumura I, et al
    Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.
    Cancer Lett. 2018;414:147-152.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  3. LI G, Yu S, Xu J, Zhang X, et al
    The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2018 Oct 22. pii: S2210-7401(18)30176.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. LI Y, Guo D, Sun R, Chen P, et al
    Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
    Dig Dis Sci. 2018 Oct 22. pii: 10.1007/s10620-018-5341.
    PubMed     Text format     Abstract available

  5. HUANG RJ, Charville GW, Hwang JH, Friedland S, et al
    A Chance to Cut Is a Chance to Cure: Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Dig Dis Sci. 2018 Oct 22. pii: 10.1007/s10620-018-5317.
    PubMed     Text format    


    Eur J Cancer

  6. NASR F, El Rassy E, Maalouf G, Azar C, et al
    Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab.
    Eur J Cancer. 2018;91:171-173.
    PubMed     Text format    


    Eur J Surg Oncol

  7. SISIC L, Blank S, Nienhuser H, Dorr S, et al
    Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Eur J Surg Oncol. 2018;44:1646-1656.
    PubMed     Text format     Abstract available

  8. CAO LL, Lu J, Lin JX, Zheng CH, et al
    Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Eur J Surg Oncol. 2018;44:1628-1633.
    PubMed     Text format     Abstract available

  9. CLAASSEN YHM, Dikken JL, Hartgrink HH, de Steur WO, et al
    North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31433.
    PubMed     Text format     Abstract available

  10. ZHAO B, Zhang J, Mei D, Luo R, et al
    Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31425.
    PubMed     Text format     Abstract available

  11. CHEN H, Tang Z, Chen L, Li H, et al
    Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.
    Eur J Surg Oncol. 2018 Oct 20. pii: S0748-7983(18)31465.
    PubMed     Text format     Abstract available


    Int J Cancer

  12. CHEN J, Guo H, Jiang H, Namusamba M, et al
    A BAP31 intrabody induces gastric cancer cell death by inhibiting p27(kip1) proteasome degradation.
    Int J Cancer. 2018 Oct 19. doi: 10.1002/ijc.31930.
    PubMed     Text format     Abstract available


    Int J Oncol

  13. XI Z, Si J, Nan J
    LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer.
    Int J Oncol. 2018 Oct 26. doi: 10.3892/ijo.2018.4609.
    PubMed     Text format     Abstract available

  14. WANG M, Qiu R, Yu S, Xu X, et al
    Paclitaxelresistant gastric cancer MGC803 cells promote epithelialtomesenchymal transition and chemoresistance in paclitaxelsensitive cells via exosomal delivery of miR1555p.
    Int J Oncol. 2018 Oct 22. doi: 10.3892/ijo.2018.4601.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  15. WU Y, Zhao T, Jia Z, Cao D, et al
    Polymorphism of the Programmed Death-Ligand 1 Gene is associated with its Protein Expression and Prognosis in Gastric Cancer.
    J Gastroenterol Hepatol. 2018 Oct 23. doi: 10.1111/jgh.14520.
    PubMed     Text format     Abstract available


    Lancet

  16. LIU JW, Ma DL
    An ominous sign from Sister Mary Joseph.
    Lancet. 2018;392:776.
    PubMed     Text format    


    Lancet Oncol

  17. NIENHUSER H, Schmidt T
    9 weeks that matter for patients with gastric cancer.
    Lancet Oncol. 2018 Oct 18. pii: S1470-2045(18)30752.
    PubMed     Text format    

  18. SHITARA K, Doi T, Dvorkin M, Mansoor W, et al
    Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2018 Oct 18. pii: S1470-2045(18)30739.
    PubMed     Text format     Abstract available


    PLoS One

  19. NAM HS, Choi CW, Kim SJ, Kang DH, et al
    Preprocedural prediction of non-curative endoscopic submucosal dissection for early gastric cancer.
    PLoS One. 2018;13:e0206179.
    PubMed     Text format     Abstract available

  20. CHOI IS, Kim JH, Lee JH, Suh KJ, et al
    A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
    PLoS One. 2018;13:e0205853.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: